Caraco Pharmaceutical Laboratories. Independent research, analysis and opininons on Caraco Pharmaceutical Laboratories
.
| Company: |
Caraco Pharmaceutical
Laboratories |
| Ticker: |
CPD |
| Profile Price: |
$8.78 September 15, 2005 |
| Sold Price |
$12.05 April 11, 2006 |
| Gain (loss) |
+37% |
| Valuation: |
$232 million |
| Website: |
http://www.caraco.com |
| Disclosure: |
This recommendation was made
prior to formation of Stock Aware, LLC |
| Original Hot Points of
Research and Analysis: |
•
Develops, manufactures
and markets generic, prescription and over the counter
pharmaceuticals in the United States. Offers drugs for the
treatment of a variety of disorders, such as hypertension,
arthritis, epilepsy, diabetes and pain management. In total,
the product portfolio comprises of seventeen prescription
products.
•
Sun Pharmaceutical Industries Limited is a majority
stockholder and has committed to the transfer of 25
products. Fourteen have already passed their bio-equivalency
strudies. Of these eleven new drug applications are pending
approval by the FDA
.•
Transfer of products
from Sun Pharmaceutical should lead to low cost product
acquisition and a higher gross margin business.
Regular updates are only available through
our Free Stock Newsletter |
